Luis Carlos Rojas-Rodríguez (Luis Carlos Rojas-Rodriguez)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Rheumatoid Arthritis Patients

Disease Activity

Cardiovascular Events

Top Venues

Medicina (Kaunas, Lithuania)

Journal of clinical medicine

Therapeutic advances in drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Daniela Baracaldo-Santamaría, John Edwin Feliciano-Alfonso, Raul Ramirez-Grueso, Luis Carlos Rojas-Rodríguez, Camilo Alberto Dominguez-Dominguez, Carlos-Alberto Calderon-Ospina
Making Sense of Composite Endpoints in Clinical Research. Journal of clinical medicine 12 (13) (2023)
Angélica María Téllez Arévalo, Abraham Quaye, Luis Carlos Rojas-Rodríguez, Brian D Poole, Daniela Baracaldo-Santamaría, Claudia M Tellez Freitas
Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety. Medicina (Kaunas, Lithuania) 59 (1) (2022)
Angélica María Téllez Arévalo, Abraham Quaye, Luis Carlos Rojas-Rodríguez, Brian D Poole, Daniela Baracaldo-Santamaría, Claudia M Tellez Freitas
Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety. Medicina (Kaunas, Lithuania) 59 (1) (2022)
Angélica María Téllez Arévalo, Abraham Quaye, Luis Carlos Rojas-Rodríguez, Brian D Poole, Daniela Baracaldo-Santamaría, Claudia M Tellez Freitas
Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety. Medicina (Kaunas, Lithuania) 59 (1) (2022)
Angélica María Téllez Arévalo, Abraham Quaye, Luis Carlos Rojas-Rodríguez, Brian D Poole, Daniela Baracaldo-Santamaría, Claudia M Tellez Freitas
Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety. Medicina (Kaunas, Lithuania) 59 (1) (2022)
Daniela Baracaldo-Santamaría, Santiago Pabón-Londoño, Luis Carlos Rojas-Rodríguez
Drug safety of frequently used drugs and substances for self-medication in COVID-19. Therapeutic advances in drug safety 13 (2022)